JAB-BX100

N/A

Report date: 2022/03/23 17:37:02
NME

Base Information

Drug NameJAB-BX100
Drug Alias NameJAB-BX100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5'-nucleotidase modulators
Targets5'-nucleotidase
Therapy Area/IndicationsColorectal NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJacobio Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJacobio Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A